NCT03534193

Brief Summary

This is a prospective, randomized trial to evaluate the effectiveness of using educational modules accessed through a bedside tablet in patients newly diagnosed with Type 1 Diabetes as an adjunct to \*standard Children's Hospital- Molly Center diabetes education in comparison to \*standard Children's Hospital- Molly Center diabetes education. (standard diabetes education consists of paper based reading material and nursing education).

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
28

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Apr 2017

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 17, 2017

Completed
1.1 years until next milestone

First Submitted

Initial submission to the registry

May 9, 2018

Completed
14 days until next milestone

First Posted

Study publicly available on registry

May 23, 2018

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2019

Completed
5.9 years until next milestone

Study Completion

Last participant's last visit for all outcomes

April 8, 2025

Completed
8 months until next milestone

Results Posted

Study results publicly available

December 17, 2025

Completed
Last Updated

December 17, 2025

Status Verified

December 1, 2025

Enrollment Period

2 years

First QC Date

May 9, 2018

Results QC Date

May 8, 2025

Last Update Submit

December 1, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Effectiveness of Tablet Education in Newly Diagnosed Type 1 Diabetes

    Effectiveness of tablet education modules as measured by a diabetic knowledge post-test questionnaire. Total score ranges from 0-100%, with a higher percentage on the scale indicating a better outcome/knowledge.

    Test will be completed on day 3 (+/- 2 days)

Secondary Outcomes (3)

  • Improved Subject Compliance With Glucose Monitoring A1 Levels

    Assessements will occur at 3 months

  • Improved Subject Compliance With Glucose Monitoring - Hypoglycemic Episodes

    Assessements will occur at 3 months

  • Improved Subject Compliance With Glucose Monitoring - Compliance With Daily Blood Glucose Monitoring

    Assessements will occur at 3 months

Study Arms (2)

Standard Diabetic Education

OTHER

Participants randomized to Group 1 will receive Standard Diabetic Education with Registered Nurse and Molly Center Diabetes Care Guide (paper-based)

Other: Molly Center Diabetes Care Guide (Paper-based)

Standard Diabetes Education and Tablet

EXPERIMENTAL

Participants randomized to Group 2 will receive Molly Center Standard Diabetes Education plus access to Tablet based interactive diabetes education modules

Other: Molly Center Diabetes Care Guide (Paper-based)Other: Tablet based interactive diabetes education modules

Interventions

Diabetes education with Registered Nurse in addition to Paper based education modules

Standard Diabetes Education and TabletStandard Diabetic Education

Molly Center Standard Diabetes Education plus access to interactive diabetes education modules through bedside tablet.

Standard Diabetes Education and Tablet

Eligibility Criteria

AgeUp to 21 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • New diagnosed Type 1 Diabetes admitted to the Joseph M. Sanzari Children's Hospital
  • Patient/Caretaker/Family willing to complete questionnaires

You may not qualify if:

  • Patients with previous history of Diabetes
  • Patients with no plans to follow up at The Joseph M. Sanzari Children's Hospital - Molly's Center for Children with Diabetes and Endocrine Disorders after hospital discharge
  • Non English speaking patients/family/caretaker

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Joseph M. Sanzari Children's Hospital

Hackensack, New Jersey, 07601, United States

Location

MeSH Terms

Conditions

Diabetes Mellitus, Type 1

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesAutoimmune DiseasesImmune System Diseases

Limitations and Caveats

The team experienced difficulties in collecting the number of blood sugar checks from the patients who did not report it for either group.

Results Point of Contact

Title
Steven Ghanny, MD
Organization
Hackensack Meridian Health

Study Officials

  • Steven Ghanny, MD

    Joseph M.Sanzari Children's Hospital at Hackensack University Medical Center

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: Participants will be randomized to one of 2 arms: Group 1 - standard Diabetic education-consisting of one on one education with a Registered Nurse in addition to the Molly Center Diabetes Care Guide (paper based) Group 2 - standard Diabetic education plus Bedside tablet with interactive Diabetic modules
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 9, 2018

First Posted

May 23, 2018

Study Start

April 17, 2017

Primary Completion

April 30, 2019

Study Completion

April 8, 2025

Last Updated

December 17, 2025

Results First Posted

December 17, 2025

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will not share

Locations